Suchergebnisse - "Weipert, Caroline M"

PubPharm (20)

1

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

enthalten in: Frontiers in oncology | 2024

von Barzi, A. | Weipert, C. | Espenschied, C. | +6

2

Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma

enthalten in: The oncologist | 2022

von Franses, J. | Lim, M. | Burgoyne, A. | +9

3

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC) : A California Cancer Consortium Phase I/II Trial (NCI 9878)

enthalten in: Clinical lung cancer | 2021

von Riess, J. | Reckamp, K. | Frankel, P. | +9

4

Novel Genomic Differences in Cell-Free Circulating DNA Profiles of Young- Versus Older-Onset Colorectal Cancer

enthalten in: Journal of adolescent and young adult oncology | 2021

von Barzi, A. | Weipert, C. | Espenschied, C. | +1

5

Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis

enthalten in: Clinical lung cancer | 2020

von Reckamp, K. | Patil, T. | Kirtane, K. | +7

6

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests : navigating moderate risk

enthalten in: Familial cancer | 2018

von West, A. | Blazer, K. | Stoll, J. | +6

7

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Panou, V. | Gadiraju, M. | Wolin, A. | +22

CommentIn: Nat Rev Clin Oncol. 2018 Nov;15(11):655. - PMID 30177683

8

The BabySeq project : implementing genomic sequencing in newborns

enthalten in: BMC pediatrics | 2018

von Holm, I. | Agrawal, P. | Ceyhan-Birsoy, O. | +66

9

Physician Experiences and Understanding of Genomic Sequencing in Oncology

enthalten in: Journal of genetic counseling | 2018

von Weipert, C. | Ryan, K. | Everett, J. | +6

10

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk

enthalten in: Familial cancer | 2018

von West, A. | Blazer, K. | Stoll, J. | +6